S2M — S2Medical AB (publ) Share Price
Last trade - 00:00- SEK10.47m
- SEK9.46m
- SEK14.91m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.89 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.7 | ||
| EV to EBITDA | 1.39 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 49.06% | ||
| Return on Equity | 85.75% | ||
| Operating Margin | 38.85% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 25.62 | 7.7 | 4.67 | 6.97 | 14.91 | n/a | n/a | 36.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
S2Medical AB (publ) is a Sweden-based medical technology company. The Company focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The Company's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The Company is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.
Directors
- Amin Omrani CHM (38)
- Petter Sivler CEO (33)
- Oskar Johansson CFO
- Marten Skog COO (36)
- Martin Zetterstrom DRC (51)
- Carsten Browall IND (63)
- Roland Frosing IND (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 18th, 2013
- Public Since
- November 28th, 2018
- No. of Employees
- 17
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 844,264,574
- Address
- Sunnorpsgatan 5, LINKOPING, 582 73
- Web
- https://www.s2m.se/
- Phone
- +46 87000050
- Auditors
- Sandbergs Redovisning & Revision AB
Upcoming Events for S2M
Similar to S2M
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 23:00 UTC, shares in S2Medical AB (publ) are trading at SEK0.01. This share price information is delayed by 15 minutes.
Shares in S2Medical AB (publ) last closed at SEK0.01 and the price had moved by -83.06% over the past 365 days. In terms of relative price strength the S2Medical AB (publ) share price has underperformed the FTSE Global All Cap Index by -83.48% over the past year.
There is no consensus recommendation for this security.
Find out moreS2Medical AB (publ) does not currently pay a dividend.
S2Medical AB (publ) does not currently pay a dividend.
S2Medical AB (publ) does not currently pay a dividend.
To buy shares in S2Medical AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.01, shares in S2Medical AB (publ) had a market capitalisation of SEK10.47m.
Here are the trading details for S2Medical AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: S2M
Based on an overall assessment of its quality, value and momentum S2Medical AB (publ) is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like S2Medical AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -20.1%.
As of the last closing price of SEK0.01, shares in S2Medical AB (publ) were trading -27.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The S2Medical AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
S2Medical AB (publ)'s management team is headed by:
- Amin Omrani - CHM
- Petter Sivler - CEO
- Oskar Johansson - CFO
- Marten Skog - COO
- Martin Zetterstrom - DRC
- Carsten Browall - IND
- Roland Frosing - IND